Item has been added

Get 20% off!arrow_drop_up

Probiotics for Eczema: Best Strains for Atopic Dermatitis Relief (Research-Backed)

  • person Nicholas Wunder
  • calendar_today
  • comment 0 comments
Illustration depicting the connection between probiotics and skin health, showing beneficial bacteria near healthy, calm skin

Probiotics for Eczema: Evidence-Based Strains for Atopic Dermatitis Relief Through the Gut-Skin Axis

What peer-reviewed research reveals about the probiotic strains, dosages, and strategies that reduce eczema severity in children and adults

Atopic dermatitis—commonly known as eczema—affects up to 20% of children and 10% of adults worldwide, making it one of the most prevalent inflammatory skin conditions on the planet.[1] For many people, the cycle of itching, redness, and flare-ups persists despite topical treatments, leaving them searching for answers that go deeper than the skin's surface.

Increasingly, that search leads to the gut. Over the past two decades, clinical research has established that the intestinal microbiome plays a direct role in eczema development and severity—a relationship mediated through what scientists call the gut-skin axis. This pathway connects gut microbial balance to immune regulation, systemic inflammation, and skin barrier integrity, providing a biological explanation for why digestive health and skin health are so closely intertwined.[2]

Probiotics have emerged as one of the most studied interventions for eczema, with dozens of randomized controlled trials now evaluating their effects on both prevention and treatment. The evidence isn't uniform across all strains—some species show remarkable clinical results while others fall short—which is why understanding which specific organisms carry the strongest research support matters enormously when choosing a supplement.

At BioPhysics Essentials, this strain-specific evidence directly shapes how we formulate MicroBiome Restore. Our 26-strain probiotic includes many of the Lactobacillus and Bifidobacterium species most extensively studied for eczema and atopic dermatitis—L. rhamnosus, L. plantarum, L. salivarius, L. fermentum, B. bifidum, B. lactis, and others detailed below. This article examines the peer-reviewed clinical evidence behind probiotics for eczema, identifies which strains show the most promise, and explains why a multi-strain synbiotic approach may offer advantages for people seeking relief.

Key Takeaways

  • A 2025 umbrella meta-analysis of 38 prior meta-analyses found that probiotic supplementation reduced the incidence of atopic dermatitis by 26% (RR = 0.74) and significantly decreased SCORAD severity scores in children.[3]
  • Lactobacillus rhamnosus HN001 halved the cumulative prevalence of eczema in high-risk infants by age 2, with protective effects persisting to age 4—two full years after supplementation ended.[4]
  • Lactobacillus plantarum IS-10506 significantly reduced SCORAD scores in both children and adults with atopic dermatitis in randomized, double-blind, placebo-controlled trials.[5][6]
  • A combination of Lactobacillus salivarius LS01 and Bifidobacterium breve BR03 ranked as the most effective probiotic supplementation for adult eczema (SUCRA 95.2%) in a systematic review and network meta-analysis.[7]
  • Multi-strain formulations combining Lactobacillus and Bifidobacterium species consistently outperform single-strain approaches for reducing eczema severity scores in subgroup analyses across multiple meta-analyses.[3][8]
  • MicroBiome Restore includes 14 of the most-studied probiotic strains for eczema and atopic dermatitis, paired with organic prebiotics and delivered in a filler-free pullulan capsule.

The Gut-Skin Axis and Eczema: Why Gut Health Matters

The connection between eczema and gut health isn't a new idea, but the research confirming it has accelerated dramatically in recent years. People with atopic dermatitis consistently show different intestinal microbiota profiles compared to healthy individuals—specifically, reduced populations of beneficial Lactobacillus and Bifidobacterium species alongside increased levels of potentially harmful bacteria like Clostridium and Staphylococcus.[2] This imbalance, known as dysbiosis, appears to both precede and perpetuate eczema symptoms.

How the Gut Communicates With the Skin

The gut-skin axis operates through several interconnected pathways. Approximately 70% of the body's immune cells reside in the gut-associated lymphoid tissue, which means that disruptions in intestinal microbial balance can trigger immune responses that manifest far from the digestive tract—including on the skin. When gut dysbiosis occurs, it can shift the immune system toward a Th2-dominant response, characterized by elevated immunoglobulin E (IgE) and pro-inflammatory cytokines like IL-4, IL-5, and IL-13—the same immunological pattern observed in atopic dermatitis.[1]

The intestinal barrier also plays a critical role. When the gut lining becomes compromised—sometimes described as increased intestinal permeability—bacterial endotoxins and inflammatory mediators can enter the bloodstream and trigger widespread immune activation. This systemic inflammation directly impacts skin barrier function, creating a feedback loop where gut dysfunction worsens skin symptoms and damaged skin further stresses the immune system. If you're noticing signs of this kind of imbalance, our guide on Lactobacillus deficiency symptoms covers the warning signals to watch for.

Dysbiosis in Eczema Patients

The microbial differences between eczema patients and healthy individuals extend to both the gut and the skin. On the skin, atopic dermatitis lesions are characterized by an overrepresentation of Staphylococcus aureus, which correlates with disease severity and flare frequency.[9] In the gut, healthy individuals harbor robust populations of Lactobacillus and Bifidobacterium species that help maintain immune homeostasis, while people with atopic diseases tend to show reduced abundance of these protective organisms.[2]

This observation carries a practical implication: if the absence of certain beneficial bacteria contributes to eczema, then restoring those populations through targeted probiotic supplementation may help address the condition at its immunological root rather than only managing surface-level symptoms. That hypothesis has now been tested in dozens of clinical trials—and the results, while nuanced, are increasingly encouraging.

While this article focuses specifically on eczema and atopic dermatitis, probiotics influence a wide range of skin conditions through the gut-skin axis. For a broader look at how gut microbial balance affects skin health overall, see our complete guide on probiotics for skin health and the gut-skin axis.

Diagram showing the gut-skin axis pathway, illustrating how intestinal microbiota influence skin health through immune signaling, inflammatory mediators, and barrier function

Understanding Eczema Severity: The SCORAD Index

Throughout the clinical studies discussed in this article, you'll encounter references to the SCORAD index (SCORing Atopic Dermatitis). This is the gold-standard tool used by researchers to objectively measure eczema severity. It evaluates three components: the extent of affected skin area, the intensity of symptoms (redness, swelling, oozing, dryness, scratching), and subjective symptoms like itch and sleep disturbance. Scores range from 0 to 103, with higher numbers indicating more severe disease. A SCORAD reduction of 8–10 points is generally considered clinically meaningful.

How Probiotics Address Eczema at the Source

Probiotics don't treat eczema the way a topical corticosteroid does—by suppressing inflammation at the skin's surface. Instead, they work through the gut-skin axis to modulate the underlying immune dysregulation that drives atopic dermatitis. Understanding these mechanisms helps explain both why probiotics can be effective and why strain selection matters so much.

Rebalancing Th1/Th2 Immune Responses

Atopic dermatitis is fundamentally an immune-mediated condition driven by an overactive Th2 response. Probiotics—particularly Lactobacillus and Bifidobacterium species—help restore balance by promoting Th1 responses and increasing regulatory T cell activity. In clinical studies, probiotic supplementation has been shown to reduce Th2 cytokines (IL-4, IL-5) while maintaining or increasing Th1 cytokines (IFN-γ, IL-12), effectively recalibrating the immune system away from the allergic phenotype that characterizes eczema.[5][10]

Strengthening Intestinal Barrier Function

By enhancing tight junction protein expression and stimulating mucin production, probiotics help strengthen the gut barrier. When the intestinal lining is intact, fewer inflammatory triggers enter the bloodstream—which means less systemic inflammation reaching the skin. Several of the Lactobacillus species studied for eczema, including L. rhamnosus and L. plantarum, have demonstrated the ability to upregulate tight junction proteins and reduce markers of intestinal permeability.[1]

Modulating IgE Production

Elevated serum IgE is a hallmark of atopic dermatitis, and several probiotic strains have shown the capacity to reduce total and allergen-specific IgE levels. In a trial involving children with eczema, L. plantarum IS-10506 supplementation for 12 weeks led to significantly lower IL-4 levels (a key driver of IgE production) compared to placebo, while increasing regulatory Foxp3+ T cell markers.[5] This immunomodulatory effect helps explain why probiotics appear most effective in allergen-sensitized patients—those whose eczema has a strong allergic component.

Reducing Staphylococcal Colonization

One of the more intriguing findings from probiotic-eczema research is that oral probiotic supplementation can alter skin microbial communities. In a randomized placebo-controlled trial of L. salivarius LS01 in adults with atopic dermatitis, the probiotic group showed a statistically significant decrease in fecal staphylococci levels by the end of treatment—and this microbial shift correlated with clinical improvement.[10] Since S. aureus colonization on the skin drives eczema flares, reducing its systemic presence may be one pathway through which oral probiotics improve skin outcomes.

Addressing Eczema From the Inside Out

MicroBiome Restore delivers 15 Billion CFU across 26 clinically researched strains—including the Lactobacillus and Bifidobacterium species most studied for atopic dermatitis support. Paired with 9 organic prebiotics in a filler-free formulation.

Explore MicroBiome Restore →

Infographic illustrating four mechanisms by which probiotics address eczema: Th1/Th2 immune rebalancing, intestinal barrier repair, IgE antibody reduction, and pathogen displacement

Best Probiotic Strains for Eczema: What the Research Shows

Not all probiotic strains affect eczema equally. The clinical literature reveals significant differences between species—and even between strains within the same species—in their ability to reduce SCORAD scores, prevent eczema development, and modulate the immune responses that drive atopic dermatitis. Here are the strains with the strongest published evidence, all of which are included in MicroBiome Restore's formulation.

Lactobacillus rhamnosus — Prevention and Treatment of Eczema

L. rhamnosus is the single most-studied probiotic species for atopic dermatitis, with evidence spanning prevention in infants through treatment in older children and adults. In a landmark randomized controlled trial, maternal and infant supplementation with L. rhamnosus HN001 halved the cumulative prevalence of eczema by age 2 (HR 0.51, 95% CI 0.30–0.85), and this protective effect persisted to at least age 4—two full years after supplementation ended (HR 0.57, 95% CI 0.39–0.83).[4]

For treatment, a double-blind, randomized trial in children aged 4–48 months with established atopic dermatitis found that 8 weeks of L. rhamnosus supplementation reduced SCORAD scores by a mean of 23.20 points in the probiotic group compared to 12.35 points in placebo (p = 0.003).[11] A separate multicenter RCT of 151 children under 2 years with eczema and cow's milk allergy found the probiotic group was 2.56 times more likely to achieve meaningful SCORAD improvement than placebo (OR 2.56, 95% CI 1.13–5.8, p = 0.012).[12] Learn more about this versatile species in our guide to Lactobacillus rhamnosus benefits.

Lactobacillus plantarum — SCORAD Reduction in Children and Adults

L. plantarum has produced some of the most consistent treatment results across age groups. In a randomized, double-blind, placebo-controlled trial, children with mild-to-moderate atopic dermatitis who received L. plantarum IS-10506 (1010 CFU/day) for 12 weeks showed significantly lower SCORAD scores, IL-4, IFN-γ, and IL-17 levels compared to controls.[5]

A follow-up RCT in adults with mild-to-moderate AD confirmed these findings: L. plantarum IS-10506 (2×1010 CFU/day) produced significant SCORAD reduction by week 8, accompanied by significant increases in regulatory Foxp3+ markers and IL-10.[6] A separate trial of L. plantarum CJLP133 in 83 children with atopic dermatitis also demonstrated significant SCORAD improvement.[13] For a broader look at this strain's clinical portfolio, see our article on Lactobacillus plantarum health benefits.

Lactobacillus salivarius — Adult Atopic Dermatitis Specialist

While much eczema research focuses on children, L. salivarius LS01 stands out for its demonstrated efficacy in adults. In a 16-week randomized, double-blind, placebo-controlled trial with 38 adult AD patients, L. salivarius LS01 produced statistically significant improvements in both SCORAD (p < 0.0001) and dermatology quality of life scores (DLQI, p = 0.021).[10] The probiotic group also showed a significant reduction in fecal staphylococci and favorable modulation of Th1/Th2 cytokine profiles.

A network meta-analysis later ranked the combination of L. salivarius LS01 and Bifidobacterium breve BR03 as the most effective probiotic supplementation for adult atopic dermatitis, achieving a SUCRA probability of 95.2%.[7] Both of these species are present in MicroBiome Restore.

Lactobacillus fermentum — Strongest Single-Strain Performer in Children

A systematic review and meta-analysis of single-strain Lactobacillus treatments for childhood AD found that L. fermentum was significantly more effective than L. plantarum, L. paracasei, or L. rhamnosus when used as a standalone intervention.[8] In a large double-blind, placebo-controlled trial of 220 children aged 1–18 with moderate-to-severe AD, both L. fermentum and L. paracasei individually produced significant SCORAD reductions compared to placebo (p < 0.001), with benefits persisting 4 months after discontinuation.[14]

Bifidobacterium bifidum — Eczema Prevention From Birth

A prenatal and postnatal supplementation trial using a mixture of B. bifidum BGN4, B. lactis AD011, and L. acidophilus AD031 found that eczema prevalence at 1 year was significantly lower in the probiotic group (18.2%) compared to placebo (40.0%, p = 0.048). The cumulative incidence of eczema during the first 12 months was also reduced significantly (36.4% vs. 62.9%, p = 0.029).[15] This trial is particularly notable because it combined three species that are all present in MicroBiome Restore. For more on this essential genus, see our guide to Bifidobacterium deficiency.

26% Reduction in atopic dermatitis incidence with probiotic supplementation across 38 meta-analyses (127,150 participants)[3]
Strain Primary Eczema Benefits Evidence Level
L. rhamnosus Prevention (halved eczema risk); SCORAD reduction in treatment Multiple Human RCTs[4][11][12]
L. plantarum SCORAD reduction, Th1/Th2 rebalancing, IgE modulation Human RCTs (children + adults)[5][6]
L. salivarius Adult AD: SCORAD + quality of life improvement Human RCT; #1 ranked in network meta-analysis[10][7]
L. fermentum SCORAD reduction; most effective single-strain Lactobacillus Human RCT (n=220) + meta-analysis[14][8]
L. paracasei SCORAD reduction in children; sustained benefits post-treatment Human RCT (n=220)[14]
L. acidophilus Eczema prevention (in combination); symptom reduction in adults Human RCTs[15][7]
L. reuteri AD management; enhanced effect combined with L. rhamnosus Human RCT (crossover design)[16]
L. casei SCORAD reduction (in combination); SCORAD improvement in children Human RCTs[12][17]
B. bifidum Eczema prevention from prenatal supplementation Human RCT (prevention)[15]
B. lactis SCORAD reduction (in combination); prevention support Human RCTs[15][17]
B. longum SCORAD reduction; reduced topical steroid use (in combination) Human RCT (JAMA Dermatol)[17]
B. breve Adult AD treatment; top-ranked combination with L. salivarius Network meta-analysis[7]
S. thermophilus Enhanced AD treatment combined with L. salivarius Human pilot study[7]

Chart ranking probiotic strains by strength of clinical evidence for eczema, with L. rhamnosus, L. plantarum, L. salivarius, and B. lactis showing the strongest research support

Probiotics for Eczema in Children: Prevention and Treatment Evidence

Childhood eczema is where probiotic research has produced some of its most compelling results. The evidence falls into two distinct categories—prevention (reducing the likelihood that eczema develops in the first place) and treatment (reducing severity in children who already have it)—and both carry meaningful implications for parents and clinicians.

Prevention: Reducing Eczema Risk Before It Starts

The strongest prevention evidence comes from studies where probiotics are administered to mothers during late pregnancy and/or to infants in early life. A 2025 umbrella meta-analysis encompassing 38 prior meta-analyses and over 127,000 participants found that probiotic supplementation significantly reduced the incidence of atopic dermatitis in children (RR = 0.74, 95% CI: 0.70–0.79).[3] The protective effect was confirmed across multiple subgroup analyses, including studies that supplemented pregnant mothers, infants, or both.

The most striking individual prevention trial involved L. rhamnosus HN001. Mothers received the probiotic from 35 weeks of gestation through 6 months postpartum (if breastfeeding), and infants continued supplementation until age 2. The probiotic group showed half the cumulative eczema prevalence of placebo by age 2, and this protection extended to at least age 4—a full two years after supplementation stopped.[4] This finding suggests that early probiotic exposure may produce lasting changes in immune development that persist well beyond the supplementation period.

Timeline comparing probiotic prevention and treatment approaches for childhood eczema, showing prenatal-to-postnatal prevention windows and 4-to-16-week treatment response phases

The prenatal/postnatal combination of B. bifidum, B. lactis, and L. acidophilus also demonstrated significant prevention efficacy, cutting eczema prevalence at one year from 40% to 18.2% in high-risk infants.[15] For parents exploring infant gut health support, our guide on probiotics for infants provides additional strain-specific information.

50% Lower cumulative eczema prevalence in infants supplemented with L. rhamnosus HN001, persisting to age 4[4]

Treatment: Reducing Eczema Severity in Children

For children who already have atopic dermatitis, the treatment evidence is robust across multiple strains. A meta-analysis of single-strain Lactobacillus interventions involving 14 clinical trials and 1,124 children found that probiotic supplementation statistically significantly reduced the SCORAD index compared to placebo (mean difference: −4.50; 95% CI: −7.50 to −1.49; p = 0.003).[8]

The magnitude of improvement varies by strain and population. The 220-child RCT by Wang and Wang demonstrated that L. paracasei, L. fermentum, and their combination all produced significant SCORAD reductions compared to placebo (p < 0.001), with benefits persisting 4 months after discontinuing treatment.[14] Notably, the study also documented improvements in family quality of life scores—a reminder that childhood eczema affects the entire household.

An important finding from the multicenter RCT by Cukrowska et al. is that probiotics appear most effective in allergen-sensitized children. While both probiotic and placebo groups showed improvement over time, the probiotic group was 6 times more likely to achieve meaningful SCORAD improvement among sensitized patients (OR 6.03, 95% CI 1.85–19.67, p = 0.001).[12] This suggests that probiotic supplementation may be especially valuable for children whose eczema has a strong allergic component.

A Note on Pediatric Use

While the clinical evidence for probiotics in childhood eczema is encouraging, parents should always consult with their child's pediatrician or dermatologist before beginning any supplement. Probiotic research in children uses specific strains at specific dosages, and individual responses can vary. MicroBiome Restore is formulated for adults; for infant-specific applications, healthcare guidance on age-appropriate preparations is essential.

Probiotics for Eczema in Adults: Clinical Findings

Adult-onset or persistent eczema presents unique challenges. Hormonal fluctuations, chronic stress, environmental exposures, and years of potential antibiotic use can all contribute to gut dysbiosis that perpetuates atopic dermatitis. While fewer large-scale trials have focused exclusively on adults compared to children, the existing evidence provides clear direction on which probiotic approaches show the most promise.

Meta-Analytic Evidence

A 2022 meta-analysis of six randomized controlled trials (n = 241 adult AD patients) found that probiotics were effective in treating adults with atopic dermatitis, producing a statistically significant decrease in SCORAD scores (Mean Difference −7.90, 95% CI −7.25 to −6.92; p < 0.05).[2] Quality of life measures also improved significantly in the probiotic groups.

The network meta-analysis by Chen et al. went further, ranking the relative effectiveness of different probiotic preparations. The combination of L. salivarius LS01 and B. breve BR03 achieved the highest probability of being the best supplementation for adult AD (SUCRA 95.2%) in both short-term and long-term outcomes. The combination of L. salivarius LS01 and S. thermophilus ST10 ranked second for short-term outcomes (SUCRA 75.6%).[7]

Individual Trial Highlights

Lactobacillus salivarius LS01 was studied in a 16-week RCT with 38 adults with moderate-to-severe AD. The probiotic group showed significant improvement in SCORAD, quality of life (DLQI), and fecal microbiota composition. Importantly, the treatment modulated Th1/Th2 cytokine balance—reducing the Th2-skewed immune profile characteristic of eczema—and significantly decreased intestinal staphylococci levels.[10]

Lactobacillus plantarum IS-10506 was tested in a double-blind, placebo-controlled trial with 30 adults with mild-to-moderate AD. The probiotic group (2×1010 CFU/day) showed significantly lower SCORAD scores by week 8, along with decreased IL-4 and IL-17 and increased regulatory Foxp3+ expression.[6]

A three-strain mixture of B. lactis CECT 8145, B. longum CECT 7347, and L. casei CECT 9104 was evaluated in a 12-week randomized, double-blind, placebo-controlled trial published in JAMA Dermatology. The probiotic group showed significant SCORAD reduction and notably decreased their use of topical corticosteroids compared to placebo.[17]

Why These Findings Matter for Supplement Selection

The network meta-analysis ranking is particularly informative for choosing a supplement. The top-performing combinations for adult eczema—L. salivarius with B. breve, L. salivarius with S. thermophilus, and the three-strain B. lactis + B. longum + L. casei mixture—all include species that are present in MicroBiome Restore. Rather than relying on a single combination, our 26-strain formulation provides the diversity to support multiple evidence-based pathways simultaneously.

For adults whose eczema may be connected to broader gut health concerns, addressing underlying digestive issues alongside probiotic supplementation can enhance results. Our evidence-based guide covers probiotics for SIBO for those dealing with bacterial overgrowth, and the article on probiotics after antibiotics addresses post-antibiotic microbiome recovery—both of which can compound eczema symptoms when left unaddressed.

Multi-Strain and Synbiotic Approaches to Eczema

If individual strains each offer distinct benefits—L. rhamnosus for prevention, L. plantarum for immune rebalancing, L. salivarius for adult AD, L. fermentum for childhood severity—does combining multiple strains produce better outcomes than any single organism alone? The evidence increasingly says yes.

Visual comparison of single-strain versus multi-strain probiotic approaches for eczema, showing how multi-strain formulas engage broader immune and gut-skin axis pathways

The Multi-Strain Advantage

The 2025 umbrella meta-analysis found that multi-strain probiotics and synbiotics significantly decreased SCORAD scores in children, while Bifidobacterium alone or prebiotics alone did not achieve statistical significance for severity reduction.[3] This finding aligns with results from several individual trials where multi-strain formulations outperformed single organisms.

The JAMA Dermatology trial demonstrated that a three-strain combination (B. lactis, B. longum, and L. casei) reduced both SCORAD scores and topical steroid dependence in moderate AD—an outcome not typically achieved with single-strain interventions at equivalent dosages.[17] Similarly, the combination of L. rhamnosus and L. reuteri in the Rosenfeldt trial showed benefits that were most pronounced in allergen-sensitized patients, with 56% of the probiotic group reporting improvement compared to only 15% on placebo.[16]

The biological rationale is straightforward: different strains target different aspects of eczema pathology. Some primarily influence Th2 cytokine suppression, others enhance regulatory T cell activity, and still others reduce intestinal permeability or alter microbial colonization patterns. A multi-strain formulation can address multiple pathways simultaneously. For a detailed comparison of supplementation strategies, our guide on single vs. multi-strain probiotics explores when each approach makes sense.

Why Prebiotics Amplify Probiotic Benefits for Eczema

Synbiotics—formulations that combine probiotics with prebiotics—have shown enhanced efficacy for eczema outcomes compared to probiotics alone. The umbrella meta-analysis confirmed that synbiotic interventions significantly reduced both AD incidence and SCORAD severity.[3] Prebiotics provide the fermentable substrates that beneficial bacteria need to colonize the gut and produce short-chain fatty acids (SCFAs)—metabolites that play a central role in immune regulation and barrier function.

MicroBiome Restore includes nine organic prebiotics designed to fuel the probiotic strains it delivers: Jerusalem artichoke (rich in inulin), maitake mushroom, fig fruit, bladderwrack, Norwegian kelp, oarweed, acacia gum, maltodextrin (for strain shelf stability), and pullulan capsules that themselves serve as a prebiotic substrate. This synbiotic design reflects the evidence showing that combining prebiotics with probiotics consistently produces stronger outcomes than either component alone.

95.2% SUCRA probability ranking L. salivarius + B. breve as the most effective probiotic combination for adult atopic dermatitis[7]

Choosing and Using Probiotics for Eczema: A Practical Guide

Translating clinical trial results into an effective personal strategy requires understanding not just which strains to look for, but how to use them, how long to expect before seeing results, and what other factors influence success.

Timeline: When to Expect Results

The clinical trials reviewed above provide a useful framework for setting expectations. Treatment-focused studies typically demonstrate measurable SCORAD improvement within 4–8 weeks, with continued benefit through 12–16 weeks of consistent supplementation. The 8-week L. rhamnosus trial showed significant severity reduction by the final assessment.[11] The 16-week L. salivarius LS01 trial documented progressive improvement in both clinical scores and quality of life throughout the treatment period.[10]

Importantly, the Wang and Wang trial with L. fermentum and L. paracasei showed that benefits persisted for at least 4 months after discontinuing the probiotic—suggesting that sustained supplementation may produce lasting changes in gut microbial ecology and immune regulation rather than merely temporary symptom suppression.[14]

A reasonable expectation: begin looking for reductions in itch intensity and flare frequency within 4–8 weeks, with more substantial improvements in overall skin appearance and SCORAD components emerging between 8–16 weeks of daily supplementation.

Checklist infographic for choosing an effective probiotic for eczema, covering strain diversity, CFU count, clean formulation, clinical evidence, and prebiotic inclusion

What to Look for in a Probiotic Supplement for Eczema

Strain specificity matters more than CFU count. The evidence is clear that some strains significantly reduce eczema severity while others show minimal effect. Prioritize products that include the strains with the strongest clinical evidence: L. rhamnosus, L. plantarum, L. salivarius, L. fermentum, B. bifidum, and B. lactis are well-supported by multiple trials.

Multi-strain formulations outperform single-strain products. Meta-analyses consistently show that combining Lactobacillus and Bifidobacterium species produces more reliable and larger reductions in eczema severity than any individual strain.[3][8]

Prebiotic inclusion enhances efficacy. Synbiotic formulations—probiotics combined with prebiotics—have demonstrated superior outcomes for eczema compared to probiotics alone.[3]

Clean formulation protects the microbiome you're trying to build. Common supplement additives like microcrystalline cellulose and flow agents have raised concerns about potential disruption to gut microbiota—counterproductive in a supplement designed to restore microbial balance. MicroBiome Restore uses no titanium dioxide, no microcrystalline cellulose, and no magnesium stearate.

Complementary Strategies for Eczema Management

Probiotic supplementation works best as part of a comprehensive approach to eczema management rather than a standalone intervention. Several lifestyle and dietary factors can support the gut-skin axis alongside probiotic use:

Dietary fiber fuels SCFA production—the same metabolites that mediate many of probiotics' immune-regulatory benefits. Increasing intake of fruits, vegetables, and whole grains provides the fermentable substrates that beneficial bacteria need to thrive.

Stress management directly impacts the gut-skin axis. Psychological stress alters gut microbiota composition, increases intestinal permeability, and elevates inflammatory markers—all of which can trigger or worsen eczema flares.[2]

Appropriate use of topical treatments remains important. Probiotics address eczema from the inside by modulating immune responses and gut health, while topical emollients, moisturizers, and prescribed treatments manage the skin barrier externally. The two approaches are complementary, not competitive—and the JAMA Dermatology trial notably found that probiotic supplementation reduced the need for topical corticosteroids, suggesting that internal support can decrease reliance on external treatments over time.[17]

Minimizing unnecessary antibiotic exposure protects the Lactobacillus and Bifidobacterium populations that support skin health. When antibiotics are medically necessary, concurrent or post-course probiotic supplementation can help restore microbial balance faster. See our probiotics after antibiotics guide for evidence-based recovery protocols.

26 Strains. 9 Organic Prebiotics. Zero Fillers.

MicroBiome Restore combines the Lactobacillus and Bifidobacterium species most studied for eczema support—including L. rhamnosus, L. plantarum, L. salivarius, L. fermentum, B. bifidum, B. lactis, and B. breve—with organic prebiotics that amplify their benefits. No microcrystalline cellulose. No magnesium stearate. No titanium dioxide. Just research-backed strains in a clean delivery system.

Explore MicroBiome Restore →

Frequently Asked Questions

What probiotics are best for eczema?

The strongest clinical evidence supports Lactobacillus rhamnosus for both prevention and treatment of eczema, Lactobacillus plantarum for reducing SCORAD severity scores in children and adults, Lactobacillus salivarius for adult atopic dermatitis, and Lactobacillus fermentum as the most effective single-strain Lactobacillus in childhood eczema. For prevention, combinations of Bifidobacterium bifidum, B. lactis, and L. acidophilus have shown significant results. Multi-strain formulations combining Lactobacillus and Bifidobacterium species consistently outperform single-strain products in meta-analyses.

Is atopic dermatitis a gut issue?

Atopic dermatitis has a significant gut component, though it's not exclusively a gut issue. Research consistently shows that people with eczema have altered intestinal microbiota—reduced Lactobacillus and Bifidobacterium and increased potentially harmful bacteria—compared to healthy individuals. This gut dysbiosis contributes to the immune dysregulation (Th2 dominance) and systemic inflammation that drive eczema symptoms. The gut-skin axis provides the biological pathway through which intestinal health influences skin condition, which is why targeting gut health through probiotics can meaningfully impact eczema severity even though the symptoms appear on the skin.

How long does it take for probiotics to help eczema?

Clinical trials show that measurable improvements in eczema severity (SCORAD reductions) typically appear within 4–8 weeks of consistent daily supplementation, with more substantial benefits emerging between 8–16 weeks. The specific timeline depends on the strain, dosage, and individual factors like baseline severity and allergen sensitization status. One encouraging finding is that benefits can persist after discontinuation—a large trial showed eczema improvements lasting at least 4 months after stopping the probiotic, suggesting lasting changes in gut ecology rather than purely temporary effects.

Can probiotics prevent eczema in babies?

Yes, multiple randomized controlled trials have demonstrated that specific probiotic strains can reduce eczema incidence in infants, particularly those at high genetic risk. The strongest evidence comes from L. rhamnosus HN001, which halved eczema prevalence by age 2 with protection lasting to at least age 4. A combination of B. bifidum, B. lactis, and L. acidophilus given to mothers prenatally and continuing postnatally reduced eczema prevalence from 40% to 18.2% at one year. A 2025 umbrella meta-analysis confirmed an overall 26% reduction in AD incidence with probiotic supplementation. Parents should consult their pediatrician before beginning any probiotic for infants.

Are probiotics safe for people with eczema?

Probiotics are generally well tolerated in eczema studies, with adverse events mainly limited to mild gastrointestinal symptoms like temporary bloating. Meta-analyses have found no significant safety concerns across thousands of participants. Rare cases of bacteremia have been reported in severely immunocompromised individuals, but this risk does not apply to typical eczema patients. As with any supplement, consult your healthcare provider before starting probiotics, especially if you have other health conditions or are taking immunosuppressive medications.

Do probiotics help eczema in adults or just children?

Probiotics help both adults and children with eczema, though the evidence base is larger for children because more trials have been conducted in pediatric populations. In adults specifically, a meta-analysis of six RCTs found significant SCORAD reduction with probiotic treatment, and a network meta-analysis identified L. salivarius LS01 combined with B. breve BR03 as the most effective supplementation for adult atopic dermatitis. L. plantarum IS-10506 has also been tested in adult-specific RCTs with positive results. Adults may need longer supplementation periods (12–16 weeks) compared to children to see full benefits.

Should I take probiotics alongside my eczema medication?

Probiotics work as complementary support alongside conventional eczema treatments, not as a replacement. In fact, one study published in JAMA Dermatology found that a multi-strain probiotic significantly reduced the need for topical corticosteroids—suggesting that gut-focused support may enhance the effectiveness of standard treatment plans. Always discuss adding probiotics with your dermatologist or allergist, particularly if you're taking systemic immunomodulatory medications. For those using antibiotics that may be disrupting gut health and worsening eczema, our guide to probiotics after antibiotics covers timing and strain selection.

Conclusion

The relationship between gut health and eczema is no longer speculative—it's supported by umbrella meta-analyses encompassing over 127,000 participants, dozens of randomized controlled trials, and a growing understanding of the biological pathways that connect intestinal microbiota to skin immune function. Specific probiotic strains, particularly Lactobacillus rhamnosus, Lactobacillus plantarum, Lactobacillus salivarius, Lactobacillus fermentum, Bifidobacterium bifidum, and Bifidobacterium lactis, have demonstrated the ability to reduce eczema incidence by up to 50% in prevention studies and produce clinically meaningful reductions in SCORAD severity scores in treatment trials.

The evidence also makes clear that not all probiotic supplements are equally suited for eczema support. Multi-strain formulations combining Lactobacillus and Bifidobacterium species consistently outperform single-strain products. Synbiotic approaches—pairing probiotics with prebiotics—show enhanced efficacy. And the specific strains matter enormously: a supplement containing well-studied species like L. rhamnosus, L. plantarum, and L. salivarius is fundamentally different from one built on less-researched organisms.

At BioPhysics Essentials, we formulated MicroBiome Restore to reflect this research. Our 26-strain synbiotic includes the Lactobacillus and Bifidobacterium species that carry the strongest evidence for eczema and atopic dermatitis support, paired with organic prebiotics that fuel their activity—all in a formulation free from the fillers and flow agents that can undermine the gut health you're working to rebuild. Because when it comes to eczema, the most effective path to calmer skin may start with a healthier gut.

References

  1. Peng, G., Fadeel, B., & Chen, B. (2023). Lactobacillus for the treatment and prevention of atopic dermatitis: Clinical and experimental evidence. Frontiers in Cellular and Infection Microbiology, 13, 1137275. https://doi.org/10.3389/fcimb.2023.1137275
  2. Umborowati, M. A., Damayanti, D., Anggraeni, S., Endaryanto, A., Surono, I. S., Effendy, I., & Prakoeswa, C. R. S. (2022). The role of probiotics in the treatment of adult atopic dermatitis: A meta-analysis of randomized controlled trials. Journal of Health, Population and Nutrition, 41(1), 37. https://doi.org/10.1186/s41043-022-00318-6
  3. Husein-ElAhmed, H., & Steinhoff, M. (2025). The impact of prebiotics, probiotics and synbiotics on the prevention and treatment of atopic dermatitis in children: An umbrella meta-analysis. Frontiers in Pediatrics, 13, 1498965. https://doi.org/10.3389/fped.2025.1498965
  4. Wickens, K., Black, P., Stanley, T. V., Mitchell, E., Barthow, C., Fitzharris, P., ... & Crane, J. (2012). A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years. Clinical & Experimental Allergy, 42(7), 1071–1079. https://doi.org/10.1111/j.1365-2222.2012.03975.x
  5. Prakoeswa, C. R. S., Herwanto, N., Prameswari, R., Astari, L., Sawitri, S., Hidayati, A. N., ... & Surono, I. S. (2017). Lactobacillus plantarum IS-10506 supplementation reduced SCORAD in children with atopic dermatitis. Beneficial Microbes, 8(5), 833–840. https://doi.org/10.3920/BM2017.0011
  6. Prakoeswa, C. R. S., Bonita, L., Karim, A., Herwanto, N., Umborowati, M. A., Setyaningrum, T., ... & Surono, I. S. (2022). Beneficial effect of Lactobacillus plantarum IS-10506 supplementation in adults with atopic dermatitis: A randomized controlled trial. Journal of Dermatological Treatment, 33(3), 1491–1498. https://doi.org/10.1080/09546634.2020.1836310
  7. Chen, Y. H., Wu, C. S., Chao, Y. H., Lin, C. C., Tsai, H. Y., Li, Y. R., ... & Chen, Y. Z. (2022). The efficacy of probiotics supplementation for the treatment of atopic dermatitis in adults: A systematic review and meta-analysis. Journal of Dermatological Treatment, 33(8), 2993–3001. https://doi.org/10.1080/09546634.2022.2080170
  8. Fang, Z., Pan, T., Li, L., Wang, H., Zhu, J., Zhang, H., ... & Chen, W. (2023). Single-strain probiotic Lactobacilli for the treatment of atopic dermatitis in children: A systematic review and meta-analysis. Pharmaceutics, 15(4), 1256. https://doi.org/10.3390/pharmaceutics15041256
  9. da Silva Ferreira, S., Braz, A. S., Cavalcanti, F. L., & Pimentel, R. F. (2022). The effect of probiotics on the clinical status of adult patients with atopic dermatitis: A systematic review. European Journal of Medical Research, 27(1), 94. https://doi.org/10.1186/s40001-022-00713-z
  10. Drago, L., Iemoli, E., Rodighiero, V., Nicola, L., De Vecchi, E., & Piconi, S. (2011). Effects of Lactobacillus salivarius LS01 (DSM 22775) treatment on adult atopic dermatitis: A randomized placebo-controlled study. International Journal of Immunopathology and Pharmacology, 24(4), 1037–1048. https://doi.org/10.1177/039463201102400421
  11. Sananpanichkul, P., Tancharoen, C., Siritippawan, T., & Pinyopornpanish, K. (2015). Evaluation of efficacy and safety of Lactobacillus rhamnosus in children aged 4–48 months with atopic dermatitis: An 8-week, double-blind, randomized, placebo-controlled study. Journal of Microbiology, Immunology and Infection, 48(2), S84. https://doi.org/10.1016/j.jmii.2015.02.055
  12. Cukrowska, B., Ceregra, A., Maciorkowska, E., Surowska, B., Zegadło-Mylik, M. A., Konopka, E., ... & Zakrzewska, M. (2021). The effectiveness of probiotic Lactobacillus rhamnosus and Lactobacillus casei strains in children with atopic dermatitis and cow's milk protein allergy: A multicenter, randomized, double blind, placebo controlled study. Nutrients, 13(4), 1169. https://doi.org/10.3390/nu13041169
  13. Han, Y., Kim, B., Ban, J., Lee, J., Kim, B. J., Choi, B. S., ... & Kim, J. (2012). A randomized trial of Lactobacillus plantarum CJLP133 for the treatment of atopic dermatitis. Pediatric Allergy and Immunology, 23(7), 667–673. https://doi.org/10.1111/pai.12010
  14. Wang, I. J., & Wang, J. Y. (2015). Children with atopic dermatitis show clinical improvement after Lactobacillus exposure. Clinical & Experimental Allergy, 45(4), 779–787. https://doi.org/10.1111/cea.12489
  15. Kim, J. Y., Kwon, J. H., Ahn, S. H., Lee, S. I., Han, Y. S., Choi, Y. O., ... & Ji, G. E. (2010). Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: A double-blind, randomized, placebo-controlled trial. Pediatric Allergy and Immunology, 21(2 Pt 2), e386–e393. https://doi.org/10.1111/j.1399-3038.2009.00958.x
  16. Rosenfeldt, V., Benfeldt, E., Nielsen, S. D., Michaelsen, K. F., Jeppesen, D. L., Valerius, N. H., & Paerregaard, A. (2003). Effect of probiotic Lactobacillus strains in children with atopic dermatitis. Journal of Allergy and Clinical Immunology, 111(2), 389–395. https://doi.org/10.1067/mai.2003.389
  17. Navarro-López, V., Ramírez-Boscá, A., Ramón-Vidal, D., Ruzafa-Costas, B., Genovés-Martínez, S., Chenoll-Cuadros, E., ... & Codoñer-Cortés, F. M. (2018). Effect of oral administration of a mixture of probiotic strains on SCORAD index and use of topical steroids in young patients with moderate atopic dermatitis: A randomized clinical trial. JAMA Dermatology, 154(1), 37–43. https://doi.org/10.1001/jamadermatol.2017.3647

About BioPhysics Essentials

BioPhysics Essentials is committed to providing science-backed, filler-free supplements that support optimal gut health. Our formulations are designed with a single priority: your wellness—never manufacturing convenience.

This article is for informational purposes only and does not constitute medical advice. Always consult with your healthcare provider before making changes to your supplement regimen, especially for the management of eczema or atopic dermatitis in children.

Nicholas Wunder profile picture

Nicholas Wunder

Learn More

Nicholas Wunder is the founder of BioPhysics Essentials. With a degree in Biology and a background in neuroscience and microbiology, he created Gut Check to cut through supplement industry marketing noise and share what the research actually says about gut health.